Project
I6T-MC-AMAX
Ongoing - recruitment active · 2022 until 2024
Eckhold Annika, Krieger-Grübel Claudia, Brand Stephan, König Marius
Type
Range
Units
Status
Start Date
End Date
Financing
Study Design
Brief description/objective
A Phase 3, Multicenter, Open-Label, Long-Term Extension Study to Evaluate
the Long-Term Efficacy and Safety of Mirikizumab in Patients with Crohn's Disease